CN116585214A - Bi-component tooth whitening gel and preparation method thereof - Google Patents
Bi-component tooth whitening gel and preparation method thereof Download PDFInfo
- Publication number
- CN116585214A CN116585214A CN202310526400.5A CN202310526400A CN116585214A CN 116585214 A CN116585214 A CN 116585214A CN 202310526400 A CN202310526400 A CN 202310526400A CN 116585214 A CN116585214 A CN 116585214A
- Authority
- CN
- China
- Prior art keywords
- component
- sodium
- whitening gel
- humectant
- tooth whitening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 84
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 238000001879 gelation Methods 0.000 title 1
- 150000002978 peroxides Chemical class 0.000 claims abstract description 31
- 239000002562 thickening agent Substances 0.000 claims abstract description 29
- 239000001506 calcium phosphate Substances 0.000 claims abstract description 15
- 229910000389 calcium phosphate Inorganic materials 0.000 claims abstract description 15
- 235000011010 calcium phosphates Nutrition 0.000 claims abstract description 15
- 239000005018 casein Substances 0.000 claims abstract description 15
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000021240 caseins Nutrition 0.000 claims abstract description 15
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 4
- 108010076119 Caseins Proteins 0.000 claims abstract 4
- 108010019954 casein phosphopeptide-amorphous calcium phosphate nanocomplex Proteins 0.000 claims abstract 4
- 229940090898 Desensitizer Drugs 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 40
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 39
- 239000003795 chemical substances by application Substances 0.000 claims description 36
- 239000008367 deionised water Substances 0.000 claims description 35
- 229910021641 deionized water Inorganic materials 0.000 claims description 35
- 229920000642 polymer Polymers 0.000 claims description 32
- 239000003906 humectant Substances 0.000 claims description 28
- 239000002105 nanoparticle Substances 0.000 claims description 25
- 239000003381 stabilizer Substances 0.000 claims description 25
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 24
- 239000003054 catalyst Substances 0.000 claims description 22
- 239000004323 potassium nitrate Substances 0.000 claims description 20
- 235000010333 potassium nitrate Nutrition 0.000 claims description 20
- 239000011775 sodium fluoride Substances 0.000 claims description 20
- 235000013024 sodium fluoride Nutrition 0.000 claims description 20
- 229960000414 sodium fluoride Drugs 0.000 claims description 20
- 239000003755 preservative agent Substances 0.000 claims description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- 239000004034 viscosity adjusting agent Substances 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 15
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 11
- 239000001301 oxygen Substances 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 235000019983 sodium metaphosphate Nutrition 0.000 claims description 11
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 229920001577 copolymer Polymers 0.000 claims description 9
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 8
- 229940091249 fluoride supplement Drugs 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 230000002335 preservative effect Effects 0.000 claims description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000013355 food flavoring agent Nutrition 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 7
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- -1 polymethylene Polymers 0.000 claims description 6
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 6
- 239000001488 sodium phosphate Substances 0.000 claims description 6
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 6
- 235000011008 sodium phosphates Nutrition 0.000 claims description 6
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 5
- TVQLLNFANZSCGY-UHFFFAOYSA-N disodium;dioxido(oxo)tin Chemical compound [Na+].[Na+].[O-][Sn]([O-])=O TVQLLNFANZSCGY-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 229940079864 sodium stannate Drugs 0.000 claims description 5
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- 239000000467 phytic acid Substances 0.000 claims description 4
- 229940068041 phytic acid Drugs 0.000 claims description 4
- 229910001414 potassium ion Inorganic materials 0.000 claims description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 4
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 3
- 229920000388 Polyphosphate Polymers 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- 229920000800 acrylic rubber Polymers 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- IOUCSUBTZWXKTA-UHFFFAOYSA-N dipotassium;dioxido(oxo)tin Chemical compound [K+].[K+].[O-][Sn]([O-])=O IOUCSUBTZWXKTA-UHFFFAOYSA-N 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 235000019800 disodium phosphate Nutrition 0.000 claims description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 claims description 3
- 229920000056 polyoxyethylene ether Polymers 0.000 claims description 3
- 229940051841 polyoxyethylene ether Drugs 0.000 claims description 3
- 239000001205 polyphosphate Substances 0.000 claims description 3
- 235000011176 polyphosphates Nutrition 0.000 claims description 3
- 229920001451 polypropylene glycol Polymers 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- 229940093932 potassium hydroxide Drugs 0.000 claims description 3
- 235000011118 potassium hydroxide Nutrition 0.000 claims description 3
- 229940093928 potassium nitrate Drugs 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 3
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 3
- 229910001631 strontium chloride Inorganic materials 0.000 claims description 3
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 claims description 3
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 3
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 3
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 claims description 3
- URDCARMUOSMFFI-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid Chemical compound OCCN(CC(O)=O)CCN(CC(O)=O)CC(O)=O URDCARMUOSMFFI-UHFFFAOYSA-N 0.000 claims description 2
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 2
- 239000003975 dentin desensitizing agent Substances 0.000 claims description 2
- 238000009775 high-speed stirring Methods 0.000 claims description 2
- 235000011083 sodium citrates Nutrition 0.000 claims description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 2
- 229960002799 stannous fluoride Drugs 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003607 modifier Substances 0.000 claims 1
- 150000001451 organic peroxides Chemical class 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 238000004061 bleaching Methods 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 10
- 230000007935 neutral effect Effects 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000005548 dental material Substances 0.000 abstract description 2
- 239000000499 gel Substances 0.000 description 57
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 29
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 18
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 18
- 239000002994 raw material Substances 0.000 description 18
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 14
- 239000003205 fragrance Substances 0.000 description 12
- 230000003020 moisturizing effect Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 229910021485 fumed silica Inorganic materials 0.000 description 10
- 239000008368 mint flavor Substances 0.000 description 10
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 10
- 239000004299 sodium benzoate Substances 0.000 description 10
- 235000010234 sodium benzoate Nutrition 0.000 description 10
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 9
- 230000003247 decreasing effect Effects 0.000 description 9
- 229910052731 fluorine Inorganic materials 0.000 description 9
- 239000011737 fluorine Substances 0.000 description 9
- 229910001629 magnesium chloride Inorganic materials 0.000 description 9
- 239000011683 manganese gluconate Substances 0.000 description 9
- 235000014012 manganese gluconate Nutrition 0.000 description 9
- 229940072543 manganese gluconate Drugs 0.000 description 9
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 210000003298 dental enamel Anatomy 0.000 description 7
- 201000002170 dentin sensitivity Diseases 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000036347 tooth sensitivity Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 3
- 229920006037 cross link polymer Polymers 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 208000036372 Sensitivity of teeth Diseases 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 230000035587 bioadhesion Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 229940096529 carboxypolymethylene Drugs 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000006084 composite stabilizer Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- NFIYTPYOYDDLGO-UHFFFAOYSA-N phosphoric acid;sodium Chemical compound [Na].OP(O)(O)=O NFIYTPYOYDDLGO-UHFFFAOYSA-N 0.000 description 2
- 229910052573 porcelain Inorganic materials 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229940048084 pyrophosphate Drugs 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 229940047670 sodium acrylate Drugs 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- CYUZOYPRAQASLN-UHFFFAOYSA-N 3-prop-2-enoyloxypropanoic acid Chemical compound OC(=O)CCOC(=O)C=C CYUZOYPRAQASLN-UHFFFAOYSA-N 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- DDAQLPYLBPPPRV-UHFFFAOYSA-N [4-(hydroxymethyl)-2-oxo-1,3,2lambda5-dioxaphosphetan-2-yl] dihydrogen phosphate Chemical compound OCC1OP(=O)(OP(O)(O)=O)O1 DDAQLPYLBPPPRV-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000004973 alkali metal peroxides Chemical class 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- HPEWZLCIOKVLBZ-UHFFFAOYSA-N barium hypochlorite Chemical compound [Ba+2].Cl[O-].Cl[O-] HPEWZLCIOKVLBZ-UHFFFAOYSA-N 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- MFLAROGHONQVRM-UHFFFAOYSA-L calcium;dihydrogen phosphate;fluoride Chemical compound [F-].[Ca+2].OP(O)([O-])=O MFLAROGHONQVRM-UHFFFAOYSA-L 0.000 description 1
- 229940078916 carbamide peroxide Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 230000000471 effect on teeth Effects 0.000 description 1
- OUDSFQBUEBFSPS-UHFFFAOYSA-N ethylenediaminetriacetic acid Chemical compound OC(=O)CNCCN(CC(O)=O)CC(O)=O OUDSFQBUEBFSPS-UHFFFAOYSA-N 0.000 description 1
- 150000002222 fluorine compounds Chemical group 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000004967 organic peroxy acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- SATVIFGJTRRDQU-UHFFFAOYSA-N potassium hypochlorite Chemical compound [K+].Cl[O-] SATVIFGJTRRDQU-UHFFFAOYSA-N 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940001593 sodium carbonate Drugs 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 229960005076 sodium hypochlorite Drugs 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 210000004357 third molar Anatomy 0.000 description 1
- 230000036344 tooth staining Effects 0.000 description 1
- 235000019798 tripotassium phosphate Nutrition 0.000 description 1
- 229910000404 tripotassium phosphate Inorganic materials 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域technical field
本发明涉及牙科材料技术领域,尤其是涉及一种双组分牙齿美白凝胶及其制备方法。The invention relates to the technical field of dental materials, in particular to a two-component tooth whitening gel and a preparation method thereof.
背景技术Background technique
在过去的100年里,随着牙齿和牙龈健康与整体健康之间的联系越来越明显,口腔护理已成为人们日常健康维护的重要部分。一个健康的微笑已经成为个人形象甚至社会地位的代表。目前常用的牙齿美白主要包括三种方式:美白牙膏、牙齿美白凝胶以及美白瓷贴面树脂修复。其中,美白牙膏很难在短时间内看到美白的效果,美白瓷贴面虽然效果明显但要磨除部分牙齿,对牙体有一定伤害。美白凝胶包括诊室美白和家庭美白两种方式。在牙科诊室,牙医使用美白剂只需30分钟或1小时就可以达到肉眼可见的美白效果。美白剂的主要成分为过氧化物,由于过氧化物不稳定,对光和热敏感,导致市面上的美白产品必须在避光冷藏储存。患者使用前需一定时间待凝胶恢复室温状态才能应用,在临床上给牙医带来诸多不便。同时由于过氧化物强烈的氧化性使得美白凝胶的粘度会随时间及温度发生明显变化,导致凝胶的有效期较短。Over the past 100 years, oral care has become an important part of people's daily health maintenance as the link between tooth and gum health and overall health has become increasingly apparent. A healthy smile has become a representative of personal image and even social status. Currently commonly used tooth whitening mainly includes three methods: whitening toothpaste, tooth whitening gel and whitening porcelain veneer resin restoration. Among them, whitening toothpaste is difficult to see the whitening effect in a short period of time. Although the effect of whitening porcelain veneer is obvious, part of the teeth must be ground away, which will cause certain damage to the teeth. Whitening gels include office whitening and home whitening. In the dental office, it only takes 30 minutes or 1 hour for the dentist to use the whitening agent to achieve the whitening effect visible to the naked eye. The main component of whitening agents is peroxide. Since peroxide is unstable and sensitive to light and heat, whitening products on the market must be stored in the dark and refrigerated. It takes a certain period of time for the patient to wait for the gel to return to room temperature before it can be applied, which brings a lot of inconvenience to the dentist clinically. At the same time, due to the strong oxidation of peroxide, the viscosity of the whitening gel will change significantly with time and temperature, resulting in a shorter validity period of the gel.
过氧化物对牙齿的美白其实质上是一个与色素进行氧化还原反应的漂白过程,可以在短时间内达到明显的漂白功效,得到了国内外研究人员及相关行业的广泛关注。但是高浓度的过氧化氢会提高牙齿的敏感性,反应同时会使牙釉质脱矿,如何降低牙齿敏感度,同时能够短时间内达到美白效果是诊室美白过程最重要的部分。因此,急需研制一种在室温条件下可以长期储存,能够缓解术后牙齿敏感的美白凝胶。The whitening of teeth by peroxide is essentially a bleaching process of redox reaction with pigment, which can achieve obvious bleaching effect in a short period of time, and has attracted extensive attention from domestic and foreign researchers and related industries. However, high concentration of hydrogen peroxide will increase the sensitivity of teeth, and the reaction will demineralize the enamel at the same time. How to reduce tooth sensitivity and achieve whitening effect in a short time is the most important part of the office whitening process. Therefore, there is an urgent need to develop a whitening gel that can be stored for a long time at room temperature and can relieve postoperative tooth sensitivity.
发明内容Contents of the invention
本发明的目的是提供一种双组分牙齿美白凝胶及其制备方法,采用自制酪蛋白磷酸肽-无定形磷酸钙CPP-ACP可释放活性钙和磷酸根离子,易形成羟基磷灰石,一方面可以使脱矿牙釉质再矿化,另一方面阻塞部分牙本质小管,辅助CPP-ACP更好地渗透牙体组织,并相互结合成再矿化能力更强的非结晶型磷酸钙氟可以更有效地缓解术后牙齿敏感。制备得到的美白凝胶可在室温储存、具有快速高效漂白功效、低敏感度、中性PH值、再矿化功效好的特点。The purpose of the present invention is to provide a two-component tooth whitening gel and its preparation method, using self-made casein phosphopeptide-amorphous calcium phosphate CPP-ACP can release active calcium and phosphate ions, easy to form hydroxyapatite, On the one hand, it can remineralize the demineralized enamel, on the other hand, it can block some dentine tubules, assist CPP-ACP to penetrate into the tooth tissue better, and combine with each other to form amorphous calcium fluoride with stronger remineralization ability Can more effectively relieve postoperative tooth sensitivity. The prepared whitening gel can be stored at room temperature, and has the characteristics of fast and efficient bleaching effect, low sensitivity, neutral pH value and good remineralization effect.
为实现上述目的,本发明提供了一种双组分牙齿美白凝胶,该美白凝胶为双组分材料,包括A组分和B组分,比例为4:1;其中A组分包括增稠剂和至少一种过氧化物或过氧化物络合物;B组分为含有酪蛋白磷酸肽-无定形磷酸钙CPP-ACP的组分。In order to achieve the above purpose, the present invention provides a two-component tooth whitening gel, which is a two-component material, including A component and B component, the ratio is 4:1; wherein A component includes whitening gel thickener and at least one peroxide or peroxide complex; component B is a component containing casein phosphopeptide-amorphous calcium phosphate CPP-ACP.
优选的,所述增稠剂为侧基带有磺酸基的高分子聚合物或共聚物。Preferably, the thickener is a high molecular polymer or copolymer with sulfonic acid groups in side groups.
进一步优选科莱恩的 polymers系列增稠剂,包括:/>BLV;/> ACL;/> TAC。Further optimization of Clariant's polymers series of thickeners, including: /> BLV; /> ACL; /> TAC.
优选的,所述A组分还包括A组分脱敏剂、A组分保湿剂和稳定剂;所述B组分还包括催化剂、粘度调节剂、纳米粒子、防腐剂、B组分保湿剂、PH调节剂和香味剂。Preferably, the A component also includes a component A desensitizer, a component A moisturizing agent and a stabilizer; the B component also includes a catalyst, a viscosity modifier, nanoparticles, preservatives, and a B component moisturizing agent , PH regulator and flavoring agent.
优选的,所述A组分包括30-50份的美白剂、0.0001-0.1份的稳定剂、0.5-3份的增稠剂、0.5-5份的A组分脱敏剂、5-20份的A组分保湿剂,余量为水;所述B组分包括,0.0003-0.0005份的催化剂、1-5份的粘度调节剂、1-5份的纳米粒子、0.5-5份的B组分脱敏剂、0.1-1份的防腐剂、5-20份的B组分保湿剂、0.5-5份的PH调节剂、0.05-1份的香味剂,余量为水。Preferably, the A component includes 30-50 parts of whitening agent, 0.0001-0.1 part of stabilizer, 0.5-3 parts of thickener, 0.5-5 parts of A component desensitizer, 5-20 parts A component moisturizing agent, the balance is water; the B component includes, 0.0003-0.0005 parts of catalyst, 1-5 parts of viscosity modifier, 1-5 parts of nanoparticles, 0.5-5 parts of B group Desensitizing agent, 0.1-1 part of preservative, 5-20 parts of B component moisturizing agent, 0.5-5 part of pH regulator, 0.05-1 part of flavoring agent, and the balance is water.
优选的,所述美白剂为释放活性氧的有机、无机过氧化物中的一种或几种。Preferably, the whitening agent is one or more of organic and inorganic peroxides that release active oxygen.
进一步优选聚乙烯吡咯烷酮-过氧化氢聚合物为美白成分,选用亚什兰的Peroxydone聚合物,Peroxydone聚合物为一种可以缓慢释放过氧化氢的药物缓释剂,可以降低由于温度光照的外界条件导致的过氧化氢迅速分解,在大部分的溶剂中能够稳定,并有着良好的亲和性、生物黏附力、成膜性和配方增稠效果。It is further preferred that polyvinylpyrrolidone-hydrogen peroxide polymer is the whitening component, and Ashland's Peroxydone polymer is selected. Peroxydone polymer is a drug slow-release agent that can slowly release hydrogen peroxide, which can reduce the external conditions due to temperature and light. The resulting hydrogen peroxide decomposes rapidly, is stable in most solvents, and has good affinity, bioadhesion, film-forming and formulation thickening effects.
优选的,所用稳定剂为锡酸钠、柠檬酸钠、乙二胺四乙酸二钠、磷酸氢钠、磷酸二氢钠、磷酸钠、三聚磷酸盐、偏磷酸钠、酒石酸、植酸、N-羟基乙基乙二胺三乙酸、氨基三乙酸、有机多元磷酸盐、脂肪族聚氧乙烯基醚的一种或多种;Preferably, the stabilizer used is sodium stannate, sodium citrate, disodium edetate, sodium hydrogen phosphate, sodium dihydrogen phosphate, sodium phosphate, tripolyphosphate, sodium metaphosphate, tartaric acid, phytic acid, N -One or more of hydroxyethylethylenediaminetriacetic acid, aminotriacetic acid, organic polyphosphate, aliphatic polyoxyethylene ether;
所述A组分脱敏剂为氟化物(氟化钠、氟化亚锡、单氟磷酸钠),钾离子(硝酸钾、柠檬酸钾,氢氧化钾、锡酸钾)、酪蛋白磷酸肽-无定形磷酸钙CPP-ACP、氯化锶、单氟磷酸钠盐中的一种或多种;The desensitizer of component A is fluoride (sodium fluoride, stannous fluoride, sodium monofluorophosphate), potassium ion (potassium nitrate, potassium citrate, potassium hydroxide, potassium stannate), casein phosphopeptide - one or more of amorphous calcium phosphate CPP-ACP, strontium chloride, sodium monofluorophosphate;
进一步优选:复合型稳定剂,复合型稳定剂对过氧化物的稳定性大于单一使用一种稳定剂的能力,焦磷酸盐优选与镁盐或锡盐连用同时添加螯合剂如EDTA-2Na或EDTA-4Na可以有效地稳定过氧化物。添加量为0.0001%-0.1%之间,加入量过多会进一步促进过氧化物的分解;A组分中所用的脱敏剂为硝酸钾和氟化钠,硝酸钾的添加量为0.5%-3%,适当浓度的硝酸钾可以有效地缓解牙齿敏感,浓度过高会导致更高的渗透梯度,使液体向外流动,从而牙龈产生疼痛。氟化钠的添加量为0.05%-0.1%;氟化物可以促进牙釉质再矿化的能力但浓度大于0.1%时则不能再提升釉质再矿化程度。Further preferred: composite stabilizer, the stability of the composite stabilizer to peroxides is greater than the ability to use a single stabilizer, pyrophosphate is preferably used in conjunction with magnesium salt or tin salt while adding a chelating agent such as EDTA-2Na or EDTA -4Na can effectively stabilize peroxides. The addition amount is between 0.0001% and 0.1%. Too much addition will further promote the decomposition of peroxide; the desensitizers used in component A are potassium nitrate and sodium fluoride, and the addition amount of potassium nitrate is 0.5%- 3%, an appropriate concentration of potassium nitrate can effectively relieve tooth sensitivity, too high a concentration will lead to a higher osmotic gradient, causing the liquid to flow outward, resulting in pain in the gums. The amount of sodium fluoride added is 0.05%-0.1%; fluoride can promote the ability of enamel remineralization, but when the concentration is greater than 0.1%, it can no longer improve the degree of enamel remineralization.
所述A组分保湿剂为聚乙二醇、山梨醇、甘油、丙二醇中的一种或多种。The moisturizing agent of the A component is one or more of polyethylene glycol, sorbitol, glycerin, and propylene glycol.
优选的,所述催化剂为促进过氧化物发生芬顿反应的有机或无极试剂。Preferably, the catalyst is an organic or nonpolar reagent that promotes the Fenton reaction of the peroxide.
优选的,所述粘度调节剂为羧基聚亚甲基聚合物丙烯酸/C10-C30烷基丙烯酸酯共聚物/>聚氧乙烯/聚氧丙烯嵌段共聚物/>以及羟丙基纤维素/>中的一种或多种。Preferably, the viscosity regulator is carboxypolymethylene polymer Acrylic acid/C10-C30 alkyl acrylate copolymer/> Polyoxyethylene/polyoxypropylene block copolymer/> and hydroxypropylcellulose/> one or more of.
优选的,所述纳米粒子为10-100nm的羟基磷灰石、10-100nm的纳米氧化锆粉末、10-100nm的二氧化硅中的一种或多种。Preferably, the nanoparticles are one or more of 10-100nm hydroxyapatite, 10-100nm nano-zirconia powder, and 10-100nm silicon dioxide.
优选的,所述酪蛋白磷酸肽-无定形磷酸钙CPP-ACP与氟化钠混合组成B组分脱敏剂;其中酪蛋白磷酸肽-无定形磷酸钙CPP-ACP为实验室自制产品,其制备过程如下:首先将50g高纯CPP,加150g缓冲溶液,50℃搅拌完全溶解,调整pH至中性,然后加入150g钙离子搅拌均匀无明显沉淀,烘干备用。Preferably, the casein phosphopeptide-amorphous calcium phosphate CPP-ACP is mixed with sodium fluoride to form component B desensitizer; wherein the casein phosphopeptide-amorphous calcium phosphate CPP-ACP is a laboratory-made product, which The preparation process is as follows: first, add 50g of high-purity CPP to 150g of buffer solution, stir at 50°C to dissolve completely, adjust the pH to neutral, then add 150g of calcium ions, stir evenly without obvious precipitation, and dry for later use.
优选的,所述B组分保湿剂为聚乙二醇、山梨醇、甘油、丙二醇中的一种或多种;Preferably, the moisturizing agent of the B component is one or more of polyethylene glycol, sorbitol, glycerin, and propylene glycol;
优选的,所述的PH调节剂为氢氧化钠、碳酸钠、三乙醇胺、柠檬酸钠、磷酸钠、磷酸二氢钠、磷酸三氢钠、焦磷酸钠、EDTA-4Na中的一种或多种。Preferably, the pH regulator is one or more of sodium hydroxide, sodium carbonate, triethanolamine, sodium citrate, sodium phosphate, sodium dihydrogen phosphate, sodium trihydrogen phosphate, sodium pyrophosphate, EDTA-4Na kind.
本发明提供了一种双组分牙齿美白凝胶的制备方法,其制备方法如下:The present invention provides a kind of preparation method of two-component teeth whitening gel, and its preparation method is as follows:
S1、配置A组分:用去离子水溶解A组分脱敏剂和稳定剂,然后加入一定量的去离子水和美白剂低温搅拌下加入增稠剂和A组分保湿剂,适当搅拌后静置一段时间,然后离心排除生产过程中的气泡。S1. Configuration of component A: Dissolve the desensitizer and stabilizer of component A with deionized water, then add a certain amount of deionized water and whitening agent, add thickener and moisturizing agent of component A under low temperature stirring, after proper stirring Let stand for a period of time, and then centrifuge to remove air bubbles in the production process.
S2、配置B组分:催化剂、B组分脱敏剂、PH调节剂、防腐剂、B组分保湿剂与一定量的去离子水混合,溶解后加入粘度调节剂和香味剂,高速搅拌加入纳米粒子,以便纳米粒子均匀分布在凝胶体系中,然后离心排除生产过程中的气泡。S2. Configure B component: Mix catalyst, B component desensitizer, PH regulator, preservative, B component humectant with a certain amount of deionized water, add viscosity modifier and fragrance after dissolving, stir at high speed and add Nanoparticles, so that the nanoparticles are evenly distributed in the gel system, and then centrifuged to remove the air bubbles during the production process.
S3、灌装A组分和B组分:选用2.5ml、4:1的双筒注射器灌装,粗管部分装A组分凝胶,细管部分装B组分凝胶,常温存放,使用时更换4:1混合针头,混合后的体系PH值为6-8之间。S3. Filling components A and B: use 2.5ml, 4:1 double-barreled syringes for filling, the part of the thick tube is filled with the gel of component A, and the part of the thin tube is filled with the gel of component B, stored at room temperature, used When changing the 4:1 mixing needle, the pH value of the mixed system is between 6-8.
因此,本发明采用上述的一种双组分牙齿美白凝胶及其制备方法,本发明的美白凝胶无需低温保存且粘度不会随时间和温度的影响而下降,置于50℃烘箱可保存14天以上,活性氧仅下降0.3%左右,粘度下降仅5%左右。同时本发明的漂白凝胶对牙齿具有低敏感度及再矿化作用,使用自制的酪蛋白磷酸肽-无定形磷酸钙(CPP-ACP)可以有效地降低漂白过程中牙齿的敏感性,使用过程中,混合后凝胶的PH值为6-8,保证美白功效的基础上避免对牙齿的酸腐蚀伤害,使得漂白后的牙齿具有较好的光泽度且色泽可长时间稳定。Therefore, the present invention adopts the above-mentioned two-component tooth whitening gel and its preparation method. The whitening gel of the present invention does not need to be stored at low temperature and its viscosity will not decrease with the influence of time and temperature. It can be stored in an oven at 50°C. After more than 14 days, the active oxygen only decreased by about 0.3%, and the viscosity decreased by only about 5%. At the same time, the bleaching gel of the present invention has low sensitivity and remineralization effect on teeth, and the use of homemade casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) can effectively reduce the sensitivity of teeth in the bleaching process. Among them, the PH value of the gel after mixing is 6-8, which can avoid acid corrosion damage to the teeth on the basis of ensuring the whitening effect, so that the teeth after bleaching have better gloss and the color can be stable for a long time.
下面通过附图和实施例,对本发明的技术方案做进一步的详细描述。The technical solutions of the present invention will be described in further detail below with reference to the accompanying drawings and embodiments.
附图说明Description of drawings
图1为本发明一种双组分牙齿美白凝胶及其制备方法实施例中不同提取液培养30min、2h、24h后细胞存活率;Fig. 1 is a kind of two-component tooth whitening gel of the present invention and its preparation method embodiment cell viability after different extracts are cultured for 30min, 2h, 24h;
图2为本发明一种双组分牙齿美白凝胶及其制备方法实施例中离体牙漂白前的图片;Fig. 2 is a picture before bleaching of isolated teeth in the embodiment of a two-component tooth whitening gel and its preparation method of the present invention;
图3为本发明一种双组分牙齿美白凝胶及其制备方法实施例中离体牙漂白后的图片。Fig. 3 is a picture of an isolated tooth after bleaching in an embodiment of a two-component tooth whitening gel and its preparation method according to the present invention.
具体实施方式Detailed ways
以下通过附图和实施例对本发明的技术方案作进一步说明。The technical solutions of the present invention will be further described below through the accompanying drawings and embodiments.
为使本发明实施例的目的、技术方案和优点更加清楚,下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本发明一部分实施例,而不是全部的实施例。通常在此处附图中描述和示出的本发明实施例的组件可以以各种不同的配置来布置和设计。In order to make the purpose, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments It is a part of embodiments of the present invention, but not all embodiments. The components of the embodiments of the invention generally described and illustrated in the figures herein may be arranged and designed in a variety of different configurations.
本发明提供了一种双组分牙齿美白凝胶,该美白凝胶为双组分材料,包括A组分和B组分,比例为4:1;其中A组分包括增稠剂和至少一种过氧化物或过氧化物络合物;B组分为含有酪蛋白磷酸肽-无定形磷酸钙CPP-ACP的组分。The invention provides a two-component tooth whitening gel, which is a two-component material, including A component and B component, the ratio is 4:1; wherein A component includes a thickener and at least one A peroxide or a peroxide complex; component B is a component containing casein phosphopeptide-amorphous calcium phosphate CPP-ACP.
增稠剂为侧基带有磺酸基的高分子聚合物或共聚物,为丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物;丙烯酰二甲基牛磺酸铵/山嵛醇聚醚-25甲基丙烯酸酯交联聚合物;丙烯酸羟乙酯/丙烯酰二甲基牛磺酸钠共聚物;丙烯酰二甲基牛磺酸铵/乙烯基吡咯烷酮共聚物;丙烯酰二甲基牛磺酸钠/乙烯基吡咯烷酮共聚物;丙烯酸钠/丙烯酰二甲基牛磺酸钠共聚物;丙烯酰二甲基牛磺酸铵/羧乙基丙烯酸酯交联聚合物中的一种或多种;进一步优选科莱恩的 polymers系列增稠剂,包括:/> BLV;/>ACL;/>TAC。The thickener is a polymer or copolymer with sulfonic acid groups in the side group, which is sodium acrylate/sodium acryloyl dimethyl taurate copolymer; ammonium acryloyl dimethyl taurate/behenyl polyether -25 Methacrylate Crosspolymer; Hydroxyethyl Acrylate/Sodium Acryloyldimethyltaurate Copolymer; Ammonium Acryloyldimethyltaurate/Vinylpyrrolidone Copolymer; Acryloyldimethyltaurate One or more of sodium sulfonate/vinylpyrrolidone copolymer; sodium acrylate/sodium acryloyldimethyltaurate copolymer; ammonium acryloyldimethyltaurate/carboxyethyl acrylate crosspolymer species; further preferred Clariant's polymers series of thickeners, including: /> BLV; /> ACL; /> TAC.
所述A组分包括美白剂:按重量份数计为30-50份;稳定剂:按重量份数计为0.0001-0.1份;增稠剂:按重量份数计为0.5-3份;A组分脱敏剂:按重量份数计为0.5-5份;A组分保湿剂:按重量份数计为5-20份;余量为水;The A component includes whitening agent: 30-50 parts by weight; stabilizer: 0.0001-0.1 parts by weight; thickener: 0.5-3 parts by weight; Component desensitizer: 0.5-5 parts by weight; component A moisturizing agent: 5-20 parts by weight; the balance is water;
美白剂包括过氧化氢、过氧化脲、碱金属过氧化物、碱金属过碳酸盐、碱金属过硼酸盐、碱金属过硫酸盐、聚乙烯吡咯烷酮-过氧化氢聚合物;甲基丙烯酸烯丙酯交联聚合物/过氧化氢络合物等以及有机过氧酸等可以释放活性氧的有机、无机过氧化物及过氧化物络合物中的一种或几种。进一步优选聚乙烯吡咯烷酮-过氧化氢聚合物为美白成分,选用亚什兰的Peroxydone聚合物,Peroxydone聚合物为一种可以缓慢释放过氧化氢的药物缓释剂,可以降低由于温度光照的外界条件导致的过氧化氢迅速分解,在大部分的溶剂中能够稳定,并有着良好的亲和性、生物黏附力、成膜性和配方增稠效果。Whitening agents include hydrogen peroxide, carbamide peroxide, alkali metal peroxides, alkali metal percarbonates, alkali metal perborates, alkali metal persulfates, polyvinylpyrrolidone-hydrogen peroxide polymers; methacrylic acid One or more of allyl ester crosslinked polymer/hydrogen peroxide complexes, organic peroxyacids, and other organic and inorganic peroxides and peroxide complexes that can release active oxygen. It is further preferred that polyvinylpyrrolidone-hydrogen peroxide polymer is the whitening component, and Ashland's Peroxydone polymer is selected. Peroxydone polymer is a drug slow-release agent that can slowly release hydrogen peroxide, which can reduce the external conditions due to temperature and light. The resulting hydrogen peroxide decomposes rapidly, is stable in most solvents, and has good affinity, bioadhesion, film-forming and formulation thickening effects.
稳定剂为锡酸钠、柠檬酸钠、乙二胺四乙酸二钠、磷酸氢钠、磷酸二氢钠、磷酸钠、三聚磷酸盐、偏磷酸钠、酒石酸、植酸、N-羟基乙基乙二胺三乙酸、羟基乙叉二磷酸、氨基三乙酸、有机多元磷酸盐、脂肪族聚氧乙烯基醚的一种或多种;A组分脱敏剂为氟化物(氟化钠、氟化亚锡、单氟磷酸钠),钾离子(硝酸钾、柠檬酸钾,氢氧化钾、锡酸钾)、酪蛋白磷酸肽-无定形磷酸钙CPP-ACP、氯化锶、单氟磷酸钠盐中的一种或多种;Stabilizers are sodium stannate, sodium citrate, disodium edetate, sodium hydrogen phosphate, sodium dihydrogen phosphate, sodium phosphate, tripolyphosphate, sodium metaphosphate, tartaric acid, phytic acid, N-hydroxyethyl One or more of ethylenediaminetriacetic acid, hydroxyethylidene diphosphate, aminotriacetic acid, organic polyphosphate, aliphatic polyoxyethylene ether; A component desensitizer is fluoride (sodium fluoride, fluoride Stannous chloride, sodium monofluorophosphate), potassium ions (potassium nitrate, potassium citrate, potassium hydroxide, potassium stannate), casein phosphopeptide-amorphous calcium phosphate CPP-ACP, strontium chloride, sodium monofluorophosphate One or more of salt;
复合型稳定剂对过氧化物的稳定性要大于单一使用一种稳定剂的能力,焦磷酸盐优选与镁盐或锡盐连用同时添加螯合剂如EDTA-2Na或EDTA-4Na可以有效地稳定过氧化物。添加量为0.0001%-0.1%之间,加入量过多会进一步促进过氧化物的分解;A组分中所用的脱敏剂为硝酸钾和氟化钠,硝酸钾的添加量为0.5%-3%,适当浓度的硝酸钾可以有效地缓解牙齿敏感,浓度过高会导致更高的渗透梯度,使液体向外流动,从而牙龈产生疼痛。氟化钠的添加量为0.05%-0.1%;氟化物可以促进牙釉质再矿化的能力但浓度大于0.1%时则不能再提升釉质再矿化程度。The stability of compound stabilizers to peroxides is greater than the ability to use a single stabilizer. Pyrophosphate is preferably used in conjunction with magnesium salts or tin salts. Adding a chelating agent such as EDTA-2Na or EDTA-4Na can effectively stabilize peroxides. oxide. The addition amount is between 0.0001% and 0.1%. Too much addition will further promote the decomposition of peroxide; the desensitizers used in component A are potassium nitrate and sodium fluoride, and the addition amount of potassium nitrate is 0.5%- 3%, an appropriate concentration of potassium nitrate can effectively relieve tooth sensitivity, too high a concentration will lead to a higher osmotic gradient, causing the liquid to flow outward, resulting in pain in the gums. The amount of sodium fluoride added is 0.05%-0.1%; fluoride can promote the ability of enamel remineralization, but when the concentration is greater than 0.1%, it can no longer improve the degree of enamel remineralization.
A组分保湿剂为聚乙二醇、山梨醇、甘油、丙二醇中的一种或多种。The moisturizer of component A is one or more of polyethylene glycol, sorbitol, glycerin, and propylene glycol.
所述B组分包括,催化剂:按重量份数计为0.0003-0.0005份;粘度调节剂:按重量份数计为1-5份;纳米粒子:按重量份数计为1-5份;B组分脱敏剂:按重量份数计为0.5-5份;防腐剂:按重量份数计为01-1份;B组分保湿剂:按重量份数计为5-20份;PH调节剂:按重量份数计为0.5-5重量份;香味剂:按重量份数计为0.05-1份;余量为水。催化剂为三聚磷酸钠、磷酸三钾、葡萄糖酸锰、硝酸铁、硫酸锰、碳酸氢钠、碳酸钠、次氯酸钠、次氯酸钾、次氯酸钙、次氯酸钡等能够促进过氧化物发生芬顿反应的有机或无极试剂。粘度调节剂为羧基聚亚甲基聚合物丙烯酸/C10-C30烷基丙烯酸酯共聚物/>聚氧乙烯/聚氧丙烯嵌段共聚物/>以及羟丙基纤维素/>中的一种或多种。纳米粒子为10-100nm的羟基磷灰石、10-100nm的纳米氧化锆粉末、10-100nm的二氧化硅中的一种或多种。The B component includes: catalyst: 0.0003-0.0005 parts by weight; viscosity regulator: 1-5 parts by weight; nanoparticles: 1-5 parts by weight; B Component desensitizer: 0.5-5 parts by weight; preservative: 0.1-1 parts by weight; component B moisturizing agent: 5-20 parts by weight; pH adjustment Agent: 0.5-5 parts by weight; flavoring agent: 0.05-1 part by weight; the balance is water. The catalyst is sodium tripolyphosphate, tripotassium phosphate, manganese gluconate, ferric nitrate, manganese sulfate, sodium bicarbonate, sodium carbonate, sodium hypochlorite, potassium hypochlorite, calcium hypochlorite, barium hypochlorite, etc., which can promote the generation of peroxide. Organic or non-polar reagents for Dundon reactions. Viscosity modifier is carboxypolymethylene polymer Acrylic acid/C10-C30 alkyl acrylate copolymer/> Polyoxyethylene/polyoxypropylene block copolymer/> and hydroxypropylcellulose/> one or more of. The nanoparticles are one or more of 10-100nm hydroxyapatite, 10-100nm nano-zirconia powder, and 10-100nm silicon dioxide.
B组分脱敏剂为酪蛋白磷酸肽-无定形磷酸钙CPP-ACP与氟化钠混合比例为1:0.1的混合物;其中酪蛋白磷酸肽-无定形磷酸钙CPP-ACP为实验室自制产品,其制备过程如下:首先将50g高纯CPP,加150g缓冲溶液,50℃搅拌完全溶解,调整pH至中性,然后加入150g钙离子搅拌均匀无明显沉淀,烘干备用。Component B desensitizer is a mixture of casein phosphopeptide-amorphous calcium phosphate CPP-ACP and sodium fluoride at a ratio of 1:0.1; among them, casein phosphopeptide-amorphous calcium phosphate CPP-ACP is a laboratory-made product , the preparation process is as follows: First, add 50g of high-purity CPP to 150g of buffer solution, stir at 50°C to dissolve completely, adjust the pH to neutral, then add 150g of calcium ions, stir evenly without obvious precipitation, and dry for later use.
B组分保湿剂为聚乙二醇、山梨醇、甘油、丙二醇、山梨醇等的一种或多种;The moisturizing agent of component B is one or more of polyethylene glycol, sorbitol, glycerin, propylene glycol, sorbitol, etc.;
PH调节剂为氢氧化钠,碳酸钠,三乙醇胺;柠檬酸钠;磷酸钠、磷酸二氢钠、磷酸三氢钠、焦磷酸钠、EDTA-4Na中的一种或多种。The pH adjusting agent is one or more of sodium hydroxide, sodium carbonate, triethanolamine; sodium citrate; sodium phosphate, sodium dihydrogen phosphate, sodium trihydrogen phosphate, sodium pyrophosphate, and EDTA-4Na.
本发明提供了一种双组分牙齿美白凝胶的制备方法,其制备方法如下:The present invention provides a kind of preparation method of two-component teeth whitening gel, and its preparation method is as follows:
S1、配置A组分:用去离子水溶解A组分脱敏剂和稳定剂,然后加入一定量的去离子水和美白剂低温搅拌下加入增稠剂和A组分保湿剂,适当搅拌后静置一段时间使增稠剂充分溶胀成凝胶状态,然后离心排除生产过程中的气泡。S1. Configuration of component A: Dissolve the desensitizer and stabilizer of component A with deionized water, then add a certain amount of deionized water and whitening agent, add thickener and moisturizing agent of component A under low temperature stirring, after proper stirring Let it stand for a period of time to make the thickener fully swell into a gel state, and then centrifuge to remove the air bubbles in the production process.
S2、配置B组分:催化剂、B组分脱敏剂、PH调节剂、防腐剂、B组分保湿剂与一定量的去离子水混合,溶解后加入粘度调节剂和香味剂,高速搅拌加入纳米粒子,以便纳米粒子均匀分布在凝胶体系中,然后离心排除生产过程中的气泡。S2. Configure B component: Mix catalyst, B component desensitizer, PH regulator, preservative, B component humectant with a certain amount of deionized water, add viscosity modifier and fragrance after dissolving, stir at high speed and add Nanoparticles, so that the nanoparticles are evenly distributed in the gel system, and then centrifuged to remove the air bubbles during the production process.
S3、灌装A组分和B组分:选用瑞士进口的2.5ml、4:1的双筒注射器灌装,粗管部分装A组分凝胶,细管部分装B组分凝胶,常温存放,使用时更换4:1混合针头,混合后的体系PH值为6-8之间。S3. Filling component A and component B: use a 2.5ml, 4:1 double-barreled syringe imported from Switzerland to fill, the thick tube part is filled with component A gel, and the thin tube part is filled with component B gel, at room temperature Store, replace the 4:1 mixing needle when using, the pH value of the mixed system is between 6-8.
实施例1Example 1
A组分原料配方:A component raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物30-50%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer 30-50%;
稳定剂:EDTA-2Na、氯化镁、偏磷酸钠比例为:1:0.5:1,添加量为0.0001%-0.1%;Stabilizer: EDTA-2Na, magnesium chloride, sodium metaphosphate ratio: 1:0.5:1, addition amount: 0.0001%-0.1%;
增稠剂: BLV:2-3%;Thickener: BLV: 2-3%;
A组分脱敏剂:硝酸钾:3%、氟化钠:0.1%;A component desensitizer: potassium nitrate: 3%, sodium fluoride: 0.1%;
A组分保湿剂:聚乙二醇400:10-20%;A component humectant: polyethylene glycol 400: 10-20%;
去离子水:10%-50%;Deionized water: 10%-50%;
B组分原料配方:B component raw material formula:
催化剂:葡萄糖酸锰:0.0003%Catalyst: Manganese Gluconate: 0.0003%
粘度调节剂:EZ-5聚合物:3%;Viscosity modifier: EZ-5 Polymer: 3%;
纳米粒子:羟基磷灰石:1%;氧化锆:1%;气相二氧化硅:0.5%;Nanoparticles: Hydroxyapatite: 1%; Zirconia: 1%; Fumed Silica: 0.5%;
B组分脱敏剂:自制含氟CPP-ACP:1%;B component desensitizer: self-made fluorine-containing CPP-ACP: 1%;
防腐剂:苯甲酸钠:0.5%;Preservatives: Sodium Benzoate: 0.5%;
B组分保湿剂:聚乙二醇400:5%-10%;Component B humectant: polyethylene glycol 400: 5%-10%;
PH调节剂:氢氧化钠和碳酸氢钠:0.5%-5%PH regulator: sodium hydroxide and sodium bicarbonate: 0.5%-5%
香味剂:薄荷香料:0.1%;Fragrance: mint flavor: 0.1%;
去离子水:10%-50%。Deionized water: 10%-50%.
工艺流程:Process flow:
首先配置A组分凝胶:在洁净的PP或PE容器内用去离子水溶解A组分脱敏剂和稳定剂,然后加入一定量的去离子水及美白剂低温搅拌下加入增稠剂和A组分保湿剂,适当搅拌后静置8小时使增稠剂充分溶胀成凝胶状态,然后离心排除生产过程中的气泡。B组分凝胶的制备流程与A组分类似,先将催化剂、B组分脱敏剂、PH调节剂、防腐剂、B组分保湿剂与一定量的去离子水混合,充分溶解后加入粘度调节剂和香精调味剂,高速搅加入纳米粒子,保证纳米粒子均匀分布在凝胶体系中,然后离心排除生产过程中的气泡。First prepare component A gel: dissolve component A desensitizer and stabilizer with deionized water in a clean PP or PE container, then add a certain amount of deionized water and whitening agent and add thickener and whitening agent under low temperature stirring Component A moisturizer, after proper stirring, let it stand for 8 hours to make the thickener fully swell into a gel state, and then centrifuge to remove the air bubbles in the production process. The preparation process of component B gel is similar to that of component A. First, mix the catalyst, component B desensitizer, pH regulator, preservative, and B component moisturizer with a certain amount of deionized water, and then add Viscosity modifier and flavoring agent, add nanoparticles by high-speed stirring to ensure that the nanoparticles are evenly distributed in the gel system, and then centrifuge to remove air bubbles during the production process.
选用瑞士进口的2.5ml、4:1的双筒注射器灌装,粗管部分装A组分凝胶,细管部分装B组分凝胶。常温存放,无需冷藏,使用时更换4:1混合针头即可。Use a 2.5ml, 4:1 double-barreled syringe imported from Switzerland for filling. The thick tube is filled with component A gel, and the thin tube is filled with component B gel. Store at room temperature, no need to refrigerate, just replace the 4:1 mixing needle when using.
其他实施例及对比例工艺流程同实施例1Other embodiment and comparative example technological process are the same as embodiment 1
实施例2Example 2
A组分原料配方:A component raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物:30-50%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer: 30-50%;
稳定剂:EDTA-4Na、氯化镁、磷酸二氢钠比例为:1:0.5:1添加量为0.0001%-0.1%;Stabilizer: EDTA-4Na, magnesium chloride, sodium dihydrogen phosphate ratio: 1:0.5:1, the addition amount is 0.0001%-0.1%;
增稠剂: TAC:2-3%;Thickener: TAC: 2-3%;
A组分脱敏剂:硝酸钾:0.5%、氟化钠:0.1%;A component desensitizer: potassium nitrate: 0.5%, sodium fluoride: 0.1%;
A组分保湿剂:甘油:5-20%;A component humectant: glycerin: 5-20%;
去离子水:10%-50%。Deionized water: 10%-50%.
B组分原料配方:B component raw material formula:
催化剂:葡萄糖酸锰:0.0003%;Catalyst: manganese gluconate: 0.0003%;
粘度调节剂:EZ-5聚合物:3%Viscosity modifier: EZ-5 Polymer: 3%
纳米粒子:羟基磷灰石:1%;氧化锆:1%;气相二氧化硅:0.5%;Nanoparticles: Hydroxyapatite: 1%; Zirconia: 1%; Fumed Silica: 0.5%;
B组分脱敏剂:自制含氟CPP-ACP:1%;B component desensitizer: self-made fluorine-containing CPP-ACP: 1%;
防腐剂:苯甲酸钠:0.5%;Preservatives: Sodium Benzoate: 0.5%;
B组分保湿剂:聚乙二醇400:5%-10%;Component B humectant: polyethylene glycol 400: 5%-10%;
PH调节剂:氢氧化钠和碳酸氢钠:0.5-5%PH regulator: sodium hydroxide and sodium bicarbonate: 0.5-5%
香味剂:薄荷香料:0.1%;Fragrance: mint flavor: 0.1%;
去离子水:10%-50%;Deionized water: 10%-50%;
实施例3Example 3
A组分原料配方:A component raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物:30-50%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer: 30-50%;
稳定剂:锡酸钠、植酸、偏磷酸钠比例为:1:1:1添加量为0.0001%-0.1%;Stabilizer: sodium stannate, phytic acid, sodium metaphosphate ratio: 1:1:1, the addition amount is 0.0001%-0.1%;
增稠剂: BLV:2-3%;Thickener: BLV: 2-3%;
A组分脱敏剂:硝酸钾:0.5%、氟化钠:0.25%;A component desensitizer: potassium nitrate: 0.5%, sodium fluoride: 0.25%;
A组分保湿剂:聚乙二醇400:10-20%;A component humectant: polyethylene glycol 400: 10-20%;
去离子水:10%-50%。Deionized water: 10%-50%.
B组分原料配方:B component raw material formula:
催化剂:硫酸锰:0.0003%;Catalyst: manganese sulfate: 0.0003%;
粘度调节剂:Pluronic F127:3%;Viscosity modifier: Pluronic F127: 3%;
纳米粒子:羟基磷灰石:1%;氧化锆:1%;气相二氧化硅:0.5%;Nanoparticles: Hydroxyapatite: 1%; Zirconia: 1%; Fumed Silica: 0.5%;
B组分脱敏剂:自制含氟CPP-ACP:1%;B component desensitizer: self-made fluorine-containing CPP-ACP: 1%;
防腐剂:苯甲酸钠:0.5%;Preservatives: Sodium Benzoate: 0.5%;
B组分保湿剂:聚乙二醇400:5%-10%;Component B humectant: polyethylene glycol 400: 5%-10%;
PH调节剂:氢氧化钠和三乙醇胺:0.5%-5%PH regulator: sodium hydroxide and triethanolamine: 0.5%-5%
香味剂:薄荷香料:0.1%;Fragrance: mint flavor: 0.1%;
去离子水:10%-50%;Deionized water: 10%-50%;
工艺流程同实施例1Technical process is the same as embodiment 1
实施例4Example 4
A组分原料配方:A component raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物:30-50%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer: 30-50%;
稳定剂:锡酸钠、氯化镁、偏磷酸钠比例为:1:0.5:1添加量为0.0001%-0.1%;Stabilizer: sodium stannate, magnesium chloride, sodium metaphosphate ratio: 1:0.5:1, the addition amount is 0.0001%-0.1%;
增稠剂: BLV:2-3%;Thickener: BLV: 2-3%;
A组分脱敏剂:硝酸钾:3%、氟化钠:0.1%;A component desensitizer: potassium nitrate: 3%, sodium fluoride: 0.1%;
A组分保湿剂:聚乙二醇40010-20%;Moisturizing agent of component A: polyethylene glycol 400 10-20%;
去离子水:10%-50%。Deionized water: 10%-50%.
B组分原料配方:B component raw material formula:
催化剂:硝酸铁0.0003%;Catalyst: 0.0003% ferric nitrate;
粘度调节剂:羟丙基纤维素HF Pharm,HXF Pharm:3%;Viscosity Modifier: Hydroxypropyl Cellulose HF Pharm, HXF Pharm: 3%;
纳米粒子:羟基磷灰石:1%;氧化锆:1%;气相二氧化硅:0.5%;Nanoparticles: Hydroxyapatite: 1%; Zirconia: 1%; Fumed Silica: 0.5%;
B组分脱敏剂:自制含氟CPP-ACP:1%;B component desensitizer: self-made fluorine-containing CPP-ACP: 1%;
防腐剂:苯甲酸钠:0.5%;Preservatives: Sodium Benzoate: 0.5%;
B组分保湿剂:聚乙二醇400:5%-10%;Component B humectant: polyethylene glycol 400: 5%-10%;
PH调节剂:氢氧化钠和柠檬酸钠:0.5%-5%PH regulator: sodium hydroxide and sodium citrate: 0.5%-5%
香味剂:薄荷香料:0.1%;Fragrance: mint flavor: 0.1%;
去离子水:10%-50%。Deionized water: 10%-50%.
对比例1Comparative example 1
A组分原料配方:A component raw material formula:
美白剂:过氧化氢30-50%;Whitening agent: 30-50% hydrogen peroxide;
稳定剂:EDTA-2Na、氯化镁、偏磷酸钠比例为:1:0.5:1,添加量为0.00001%;Stabilizer: EDTA-2Na, magnesium chloride, sodium metaphosphate ratio: 1:0.5:1, adding amount: 0.00001%;
增稠剂: BLV:2-3%;Thickener: BLV: 2-3%;
A组分脱敏剂:硝酸钾3%、氟化钠:0.1%;A component desensitizer: potassium nitrate 3%, sodium fluoride: 0.1%;
A组分保湿剂:聚乙二醇400:10-20%;A component humectant: polyethylene glycol 400: 10-20%;
去离子水:10%-50%。Deionized water: 10%-50%.
B组分原料配方:B component raw material formula:
催化剂:葡萄糖酸锰:0.0003%;Catalyst: manganese gluconate: 0.0003%;
粘度调节剂:EZ-5聚合物:3%;Viscosity modifier: EZ-5 Polymer: 3%;
纳米粒子:羟基磷灰石:1%;氧化锆:1%;气相二氧化硅:0.5%;Nanoparticles: Hydroxyapatite: 1%; Zirconia: 1%; Fumed Silica: 0.5%;
B组分脱敏剂:自制含氟CPP-ACP:1%;B component desensitizer: self-made fluorine-containing CPP-ACP: 1%;
防腐剂:苯甲酸钠:0.5%;Preservatives: Sodium Benzoate: 0.5%;
B组分保湿剂:聚乙二醇400:5%-10%;Component B humectant: polyethylene glycol 400: 5%-10%;
PH调节剂:氢氧化钠和碳酸氢钠:0.5%-5%PH regulator: sodium hydroxide and sodium bicarbonate: 0.5%-5%
香味剂:薄荷香料:0.1%;Fragrance: mint flavor: 0.1%;
去离子水:10%-50%。Deionized water: 10%-50%.
对比例2Comparative example 2
A组分原料配方:A component raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物:30-50%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer: 30-50%;
稳定剂:EDTA-2钠、氯化镁、偏磷酸钠比例为:1:0.5:1添加量为0.0001%-0.1%;Stabilizer: EDTA-2 sodium, magnesium chloride, sodium metaphosphate ratio: 1:0.5:1, the addition amount is 0.0001%-0.1%;
增稠剂: BLV:0.1-0.3%;Thickener: BLV: 0.1-0.3%;
A组分脱敏剂:硝酸钾3%、氟化钠:0.1%;A component desensitizer: potassium nitrate 3%, sodium fluoride: 0.1%;
A组分保湿剂:聚乙二醇400:10-20%;A component humectant: polyethylene glycol 400: 10-20%;
去离子水:10%-50%。Deionized water: 10%-50%.
B组分原料配方:B component raw material formula:
催化剂:葡萄糖酸锰:0.0003%;Catalyst: manganese gluconate: 0.0003%;
粘度调节剂:EZ-5聚合物:3%;Viscosity modifier: EZ-5 Polymer: 3%;
纳米粒子:羟基磷灰石1%;氧化锆1%;气相二氧化硅:0.5%;Nanoparticles: hydroxyapatite 1%; zirconia 1%; fumed silica: 0.5%;
B组分脱敏剂:硝酸钾:1%;B component desensitizer: Potassium nitrate: 1%;
防腐剂:苯甲酸钠:0.5%;Preservatives: Sodium Benzoate: 0.5%;
B组分保湿剂:聚乙二醇400:5%-10%;Component B humectant: polyethylene glycol 400: 5%-10%;
PH调节剂:氢氧化钠和碳酸氢钠:0.5-5%PH regulator: sodium hydroxide and sodium bicarbonate: 0.5-5%
香味剂:薄荷香料:0.1%;Fragrance: mint flavor: 0.1%;
去离子水:10%-50%。Deionized water: 10%-50%.
对比例3Comparative example 3
A组分凝胶原料配方:A component gel raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物10-20%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer 10-20%;
稳定剂:EDTA-2钠、氯化镁、偏磷酸钠比例为:1:0.5:1添加量为0.0001%-0.1%;Stabilizer: EDTA-2 sodium, magnesium chloride, sodium metaphosphate ratio: 1:0.5:1, the addition amount is 0.0001%-0.1%;
增稠剂: BLV:2-3%;Thickener: BLV: 2-3%;
A组分脱敏剂:硝酸钾:3%、氟化钠:0.1%A component desensitizer: potassium nitrate: 3%, sodium fluoride: 0.1%
A组分保湿剂:聚乙二醇400:10-20%Component A Humectant: Polyethylene Glycol 400: 10-20%
去离子水:10%-50%Deionized water: 10%-50%
B组凝胶分原料配方:Group B gel ingredient formula:
催化剂:葡萄糖酸锰:0.0003%;Catalyst: manganese gluconate: 0.0003%;
粘度调节剂:EZ-5聚合物:3%Viscosity modifier: EZ-5 Polymer: 3%
纳米粒子:羟基磷灰石1%;氧化锆1%;气相二氧化硅:0.5%B组分脱敏剂:含氟CPP-ACP:1%;Nanoparticles: hydroxyapatite 1%; zirconia 1%; fumed silica: 0.5% B component desensitizer: fluorine-containing CPP-ACP: 1%;
防腐剂:苯甲酸钠:0.5%Preservatives: Sodium Benzoate: 0.5%
B组分保湿剂:聚乙二醇400:5%-10%Component B humectant: Polyethylene glycol 400: 5%-10%
PH调节剂:氢氧化钠和碳酸氢钠:0.5%-5%PH regulator: sodium hydroxide and sodium bicarbonate: 0.5%-5%
香味剂:薄荷香料:0.1%Fragrance: Mint Flavor: 0.1%
去离子水:10%-50%Deionized water: 10%-50%
对比例4Comparative example 4
A组分凝胶原料配方:A component gel raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物:30-50%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer: 30-50%;
稳定剂:氯化镁:0.0001%-0.1%;Stabilizer: magnesium chloride: 0.0001%-0.1%;
增稠剂: BLV:2-3%;Thickener: BLV: 2-3%;
A组分脱敏剂:硝酸钾3%、氟化钠:0.1%A component desensitizer: potassium nitrate 3%, sodium fluoride: 0.1%
A组分保湿剂:聚乙二醇400:10-20%Component A Humectant: Polyethylene Glycol 400: 10-20%
去离子水:10%-50%Deionized water: 10%-50%
B组凝胶分原料配方:Group B gel ingredient formula:
催化剂:葡萄糖酸锰:0.0003%;Catalyst: manganese gluconate: 0.0003%;
粘度调节剂:EZ-5聚合物:3%Viscosity modifier: EZ-5 Polymer: 3%
纳米粒子:羟基磷灰石1%;氧化锆1%;气相二氧化硅:0.5%B组分脱敏剂:含氟CPP-ACP:1%;Nanoparticles: hydroxyapatite 1%; zirconia 1%; fumed silica: 0.5% B component desensitizer: fluorine-containing CPP-ACP: 1%;
防腐剂:苯甲酸钠:0.5%Preservatives: Sodium Benzoate: 0.5%
B组分保湿剂:聚乙二醇400:5%-10%Component B humectant: Polyethylene glycol 400: 5%-10%
PH调节剂:氢氧化钠和碳酸氢钠:0.5%-5%PH regulator: sodium hydroxide and sodium bicarbonate: 0.5%-5%
香味剂:薄荷香料:0.1%Fragrance: Mint Flavor: 0.1%
去离子水:10%-50%Deionized water: 10%-50%
对比例5Comparative example 5
A组分凝胶原料配方:A component gel raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物30-50%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer 30-50%;
稳定剂:EDTA-2钠、氯化镁、偏磷酸钠比例为:1:0.5:1添加量为0.0001%-0.1%;Stabilizer: EDTA-2 sodium, magnesium chloride, sodium metaphosphate ratio: 1:0.5:1, the addition amount is 0.0001%-0.1%;
增稠剂: BLV:2-3%;Thickener: BLV: 2-3%;
脱敏剂:硝酸钾3%、氟化钠:0.1%Desensitizer: potassium nitrate 3%, sodium fluoride: 0.1%
保湿剂:聚乙二醇400:10-20%Moisturizer: Macrogol 400: 10-20%
去离子水:10%-50%Deionized water: 10%-50%
B组分凝胶原料配方:B component gel raw material formula:
催化剂:葡萄糖酸锰:0.0003%;Catalyst: manganese gluconate: 0.0003%;
粘度调节剂:EZ-5聚合物:3%Viscosity modifier: EZ-5 Polymer: 3%
纳米粒子:羟基磷灰石1%;氧化锆1%;气相二氧化硅:0.5%Nanoparticles: Hydroxyapatite 1%; Zirconia 1%; Fumed Silica: 0.5%
B组分脱敏剂:自制含氟CPP-ACP:0.1%;B component desensitizer: self-made fluorine-containing CPP-ACP: 0.1%;
防腐剂:苯甲酸钠:0.5%Preservatives: Sodium Benzoate: 0.5%
B组分保湿剂:聚乙二醇400:5%-10%Component B humectant: Polyethylene glycol 400: 5%-10%
PH调节剂:氢氧化钠和碳酸氢钠:0.5%-5%PH regulator: sodium hydroxide and sodium bicarbonate: 0.5%-5%
香味剂:薄荷香料:0.1%Fragrance: Mint Flavor: 0.1%
去离子水:10%-50%Deionized water: 10%-50%
对比例6Comparative example 6
A组分凝胶原料配方:A component gel raw material formula:
美白剂:聚乙烯吡咯烷酮-过氧化氢聚合物30-50%;Whitening agent: polyvinylpyrrolidone-hydrogen peroxide polymer 30-50%;
稳定剂:EDTA-2Na、氯化镁、偏磷酸钠的比例为:1:0.5:1添加量为0.0001%-0.1%;Stabilizer: the ratio of EDTA-2Na, magnesium chloride, and sodium metaphosphate: 1:0.5:1, the addition amount is 0.0001%-0.1%;
增稠剂: BLV:2-3%;Thickener: BLV: 2-3%;
A组分脱敏剂:硝酸钾3%、氟化钠:0.1%A component desensitizer: potassium nitrate 3%, sodium fluoride: 0.1%
A组分保湿剂:聚乙二醇400:10-20%Component A Humectant: Polyethylene Glycol 400: 10-20%
去离子水:10%-50%Deionized water: 10%-50%
B组分凝胶原料配方:B component gel raw material formula:
催化剂:葡萄糖酸锰:0.0001%;Catalyst: manganese gluconate: 0.0001%;
粘度调节剂:EZ-5聚合物:3%;Viscosity modifier: EZ-5 Polymer: 3%;
纳米粒子:羟基磷灰石1%;氧化锆1%;气相二氧化硅:0.5%;Nanoparticles: hydroxyapatite 1%; zirconia 1%; fumed silica: 0.5%;
B组分脱敏剂:自制含氟CPP-ACP:1%;B component desensitizer: self-made fluorine-containing CPP-ACP: 1%;
防腐剂:苯甲酸钠:0.5%;Preservatives: Sodium Benzoate: 0.5%;
B组分保湿剂:聚乙二醇400:5%-10%;Component B humectant: polyethylene glycol 400: 5%-10%;
PH调节剂:氢氧化钠和碳酸氢钠:0.5%-5%;PH regulator: sodium hydroxide and sodium bicarbonate: 0.5%-5%;
香味剂:薄荷香料:0.1%;Fragrance: mint flavor: 0.1%;
去离子水:10%-50%Deionized water: 10%-50%
1、活性氧含量试验测试:1. Active oxygen content test test:
参照YY T0632-2008牙齿外漂白过氧化物含量测试。实验过程如下:Refer to YY T0632-2008 tooth bleaching peroxide content test. The experimental process is as follows:
称取一定量的美白凝胶于50mL烧杯中,加入20mL去离子水,将烧杯放于磁力搅拌器上搅拌均匀,转入250mL碘量瓶中。加入5mL冰乙酸,用100mL去离子水将烧杯冲洗干净并转入到碘量瓶中,加入2g碘化钾,2滴10%的钼酸胺,溶液呈橙黄色。暗处放置10min后,取出后用上述标定过的硫代硫酸钠滴定,近终点时,加入3mL10%淀粉,继续滴定至溶液无色(30s内不变色),记下所消耗的硫代硫酸钠标准溶液的量,同时做空白试验。Weigh a certain amount of whitening gel into a 50mL beaker, add 20mL deionized water, put the beaker on a magnetic stirrer and stir evenly, then transfer it to a 250mL iodine bottle. Add 5 mL of glacial acetic acid, rinse the beaker with 100 mL of deionized water and transfer it to an iodine flask, add 2 g of potassium iodide and 2 drops of 10% ammonium molybdate, and the solution is orange-yellow. After standing in the dark for 10 minutes, take it out and titrate with the above-mentioned calibrated sodium thiosulfate. When the end point is near, add 3mL of 10% starch and continue titrating until the solution is colorless (it does not change color within 30s), and record the consumed sodium thiosulfate. The amount of standard solution, while doing a blank test.
实验结果:Experimental results:
实施例1-4过氧化物含量:38%Embodiment 1-4 peroxide content: 38%
对比例1-2,4-6过氧化物含量:38%Comparative example 1-2, 4-6 peroxide content: 38%
对比例3为过氧化物含量:18%Comparative example 3 is peroxide content: 18%
市售美白凝胶1过氧化物含量:37%Commercially available whitening gel 1 peroxide content: 37%
市售美白凝胶2过氧化物含量:40%Commercially available whitening gel 2 peroxide content: 40%
2、老化实验测试:2. Aging test:
将实施例1-4、对比例1-6及市售美白凝胶1、市售美白凝胶2产品置于50℃烘箱保存14天进行老化实验,测试实验前后过氧化氢含量变化,使用美国博勒飞Brookfield旋转粘度仪测量样品老化前后粘度变化,其结果如表1所示。Examples 1-4, Comparative Examples 1-6, commercially available whitening gel 1, and commercially available whitening gel 2 were stored in an oven at 50°C for 14 days for aging experiments, and the changes in hydrogen peroxide content before and after the experiment were tested. Brookfield rotational viscometer measured the viscosity change of the sample before and after aging, and the results are shown in Table 1.
表1实施例、对比例及市售美白凝胶老化后活性氧含量及粘度数据对比表Table 1 Comparison Table of Active Oxygen Content and Viscosity Data of Examples, Comparative Examples, and Commercially Available Whitening Gels After Aging
实验结果:对比例1老化3天后出现爆管现象,其他样品均可完成老化实验。老化后实施例1-4及对比例2-6活性氧含量下降0.2-3.5%;市售美白凝胶1活性氧含量下降4.5%;市售美白凝胶2活性氧含量下降2%。Experimental results: Tube burst phenomenon occurred after 3 days of aging in comparative example 1, and the aging experiment could be completed for other samples. After aging, the active oxygen content of Examples 1-4 and Comparative Examples 2-6 decreased by 0.2-3.5%; the active oxygen content of commercially available whitening gel 1 decreased by 4.5%; the active oxygen content of commercially available whitening gel 2 decreased by 2%.
老化后实施例1-4粘度下降4.5-5.8%;对比例2-6粘度下降5.5-23.6%;市售美白凝胶1活性氧含量下降10.3%;市售美白凝胶2活性氧含量下降14.6%。After aging, the viscosity of Example 1-4 decreased by 4.5-5.8%; the viscosity of Comparative Example 2-6 decreased by 5.5-23.6%; the active oxygen content of commercially available whitening gel 1 decreased by 10.3%; the active oxygen content of commercially available whitening gel 2 decreased by 14.6% %.
3、敏感性体外细胞实验:3. Sensitive in vitro cell experiments:
取门诊拔除的健康第三磨牙,用含双抗的PBS液反复清洗牙齿后,无菌条件下分离牙髓,剪成约1.0mm3的碎块平铺于α-MEM培养液的六孔板内;The healthy third molars extracted in outpatient service were taken, and after the teeth were repeatedly cleaned with PBS solution containing double antibodies, the pulp was separated under aseptic conditions, cut into pieces of about 1.0 mm 3 and spread on a six-well plate in α-MEM culture medium Inside;
37℃、5%CO2的孵箱中培养,每3d换液1次;将混合后的美白凝胶提取液稀释至10%、5%、2%的稀释液滴加在上述培养基种,培养30min、2h、24h后观察细胞存活率,其结果如图1所示。Cultivate in an incubator at 37°C and 5% CO 2 , and change the medium every 3 days; dilute the mixed whitening gel extract to 10%, 5%, and 2% dilutions and add them dropwise to the above medium. After culturing for 30 min, 2 h, and 24 h, the cell viability was observed, and the results are shown in Figure 1.
4、漂白试验测试:4. Bleaching test:
以门诊拔除的离体牙为实验对象,用咖啡、红茶、FeCl3和粘蛋白等配制成染色液,在染牙机上染色7天,从而在牙齿的表面形成一层外源性色斑,其形成机理以及组成成分与真实的色斑接近。然后美白凝胶混合后涂抹于牙齿表面,停留8min后用去离子水去除凝胶反复涂抹4次,利用vita比色卡对比漂白前后颜色变化,结果如图2-3所示,可以明显看出美白32min后明显白于初始样品。Taking isolated teeth extracted in outpatient clinics as the experimental object, the staining solution was prepared with coffee, black tea, FeCl 3 and mucin, etc., and stained on a tooth staining machine for 7 days, thereby forming a layer of exogenous stains on the surface of the teeth. The formation mechanism and composition are close to the real stain. Then the whitening gel is mixed and applied to the surface of the teeth. After staying for 8 minutes, remove the gel with deionized water and apply it repeatedly 4 times. Use the vita color chart to compare the color changes before and after bleaching. The results are shown in Figure 2-3, which can be clearly seen After 32 minutes of whitening, it is obviously whiter than the original sample.
因此,本发明采用上述一种双组分牙齿美白凝胶及其制备方法,采用自制酪蛋白磷酸肽-无定形磷酸钙CPP-ACP可释放活性钙和磷酸根离子,易形成羟基磷灰石,一方面可以使脱矿牙釉质再矿化,另一方面阻塞部分牙本质小管,从而减轻牙齿敏感性。由于体系中氟离子的存在,可辅助CPP-ACP更好地渗透牙体组织,并相互结合成再矿化能力更强的非结晶型磷酸钙氟可以更有效地缓解术后牙齿敏感。制备得到的美白凝胶可在室温储存、具有快速高效漂白功效、低敏感度、中性PH值、再矿化功效好的特点。Therefore, the present invention adopts the above-mentioned two-component tooth whitening gel and its preparation method, adopts self-made casein phosphopeptide-amorphous calcium phosphate CPP-ACP to release active calcium and phosphate ions, and easily forms hydroxyapatite, On the one hand, it can remineralize the demineralized enamel, and on the other hand, it can block some dentine tubules, thereby reducing tooth sensitivity. Due to the existence of fluoride ions in the system, it can assist CPP-ACP to better penetrate the tooth tissue, and combine with each other to form amorphous calcium phosphate fluoride with stronger remineralization ability, which can more effectively relieve postoperative tooth sensitivity. The prepared whitening gel can be stored at room temperature, and has the characteristics of fast and efficient bleaching effect, low sensitivity, neutral pH value and good remineralization effect.
最后应说明的是:以上实施例仅用以说明本发明的技术方案而非对其进行限制,尽管参照较佳实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对本发明的技术方案进行修改或者等同替换,而这些修改或者等同替换亦不能使修改后的技术方案脱离本发明技术方案的精神和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and not to limit them. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that: it still Modifications or equivalent replacements can be made to the technical solutions of the present invention, and these modifications or equivalent replacements cannot make the modified technical solutions deviate from the spirit and scope of the technical solutions of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310526400.5A CN116585214A (en) | 2023-05-11 | 2023-05-11 | Bi-component tooth whitening gel and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310526400.5A CN116585214A (en) | 2023-05-11 | 2023-05-11 | Bi-component tooth whitening gel and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116585214A true CN116585214A (en) | 2023-08-15 |
Family
ID=87603889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310526400.5A Pending CN116585214A (en) | 2023-05-11 | 2023-05-11 | Bi-component tooth whitening gel and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116585214A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2025055467A1 (en) * | 2023-09-15 | 2025-03-20 | 西岭(镇江)医疗科技有限公司 | Tooth whitening gel and preparation method therefor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434315A (en) * | 2016-01-08 | 2016-03-30 | 青岛康尔生物工程有限公司 | Gum-protecting whitening toothpaste and preparation method thereof |
CN114652632A (en) * | 2022-02-25 | 2022-06-24 | 华南农业大学 | Preparation method of casein phosphopeptide-amorphous calcium phosphate |
CN115919685A (en) * | 2022-11-18 | 2023-04-07 | 杭州纳美智康科技有限公司 | Double-tube whitening toothpaste and preparation method thereof |
-
2023
- 2023-05-11 CN CN202310526400.5A patent/CN116585214A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434315A (en) * | 2016-01-08 | 2016-03-30 | 青岛康尔生物工程有限公司 | Gum-protecting whitening toothpaste and preparation method thereof |
CN114652632A (en) * | 2022-02-25 | 2022-06-24 | 华南农业大学 | Preparation method of casein phosphopeptide-amorphous calcium phosphate |
CN115919685A (en) * | 2022-11-18 | 2023-04-07 | 杭州纳美智康科技有限公司 | Double-tube whitening toothpaste and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2025055467A1 (en) * | 2023-09-15 | 2025-03-20 | 西岭(镇江)医疗科技有限公司 | Tooth whitening gel and preparation method therefor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9138386B2 (en) | Dental whitening compositions | |
US5846570A (en) | Stabilized hydrogen peroxide gel compositions | |
US5171564A (en) | Aqueous tooth whitening dentifrice | |
AU660691B2 (en) | Abrasive tooth whitening dentifrice of improved stability | |
CA2671655C (en) | Improved teeth whitening compositions comprising an adhesive polymer, a whitening active, and a penetration enhancer | |
US4638823A (en) | Fluoride-coated dental floss | |
US4548219A (en) | Fluoride-coated dental floss | |
CN104981273A (en) | Oral care composition | |
US6534043B2 (en) | Stable peroxide dental compositions | |
WO1998004235A1 (en) | Chlorine dioxide tooth whitening compositions | |
CN116585214A (en) | Bi-component tooth whitening gel and preparation method thereof | |
JP2007008874A (en) | Pasty dental bleaching material | |
CN108542800A (en) | A kind of tooth whitening gel and its preparation and application | |
US5788951A (en) | Dual component dentifrice composition for fluoridating teeth containing compatible silica abrasive | |
CN115634160A (en) | Tooth whitening composition and preparation method thereof | |
JP2020535166A (en) | Aqueous Oral Care Fluoride Treatment Compositions and Methods | |
US12042555B2 (en) | Anti-stain oral care composition | |
CN109549858B (en) | Gel for whitening teeth and preparation method thereof | |
CN109199909B (en) | Baking soda toothpaste | |
CN115645288B (en) | Gel for tooth whitening, preparation method and kit for tooth whitening | |
CN101829033B (en) | Three-component tooth stain scavenger | |
CN110623867A (en) | Tooth whitening composition with whitening and stain removing effects and preparation method thereof | |
CN112773727B (en) | Preparation method of a stain-removing and whitening biological lysozyme toothpaste composition | |
CN117530900A (en) | Peroxide-free tooth whitening gel and method of use | |
CN116942566A (en) | Toothpaste composition and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |